Should anthracyclines and dexrazoxane be used for children with cancer?

Elvira C. van Dalen, Henk van den Berg, Martine F. Raphaël, Huib N. Caron, Leontien C. Kremer

Research output: Contribution to journal › Comment/Letter to the editor › Academic

15 Citations (Scopus)

Original language	English
Pages (from-to)	12-13
Journal	lancet oncology
Volume	12
Issue number	1
DOIs	https://doi.org/10.1016/S1470-2045(10)70301-6
Publication status	Published - 2011

Access to Document

https://doi.org/10.1016/S1470-2045(10)70301-6

Cite this

@article{a5897d9a7a944c309ede7125c0e40124,

title = "Should anthracyclines and dexrazoxane be used for children with cancer?",

author = "{van Dalen}, {Elvira C.} and {van den Berg}, Henk and Rapha{\"e}l, {Martine F.} and Caron, {Huib N.} and Kremer, {Leontien C.}",

year = "2011",

doi = "https://doi.org/10.1016/S1470-2045(10)70301-6",

language = "English",

volume = "12",

pages = "12--13",

journal = "lancet oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "1",

}

TY - JOUR

T1 - Should anthracyclines and dexrazoxane be used for children with cancer?

AU - van Dalen, Elvira C.

AU - van den Berg, Henk

AU - Raphaël, Martine F.

AU - Caron, Huib N.

AU - Kremer, Leontien C.

PY - 2011

Y1 - 2011

U2 - https://doi.org/10.1016/S1470-2045(10)70301-6

DO - https://doi.org/10.1016/S1470-2045(10)70301-6

M3 - Comment/Letter to the editor

C2 - 21195321

SN - 1470-2045

VL - 12

SP - 12

EP - 13

JO - lancet oncology

JF - lancet oncology

IS - 1

ER -